Clinical Trial Update: Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe

View source ↗

Summary

A completed post-marketing safety surveillance study assessing exposure to atazanavir in HIV-infected children in Europe. The program monitors safety signals fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infection | Status: COMPLETED